Co-occurrence of interstitial lung disease and pulmonary embolism as adverse events of adjuvant osimertinib treatment for EGFR mutant non-small cell lung cancer: a case report by Kenta Manabe, Kazuhiko Shien, Shinichi Furukawa, Tomoya Seno, Kousei Ishimura, Shin Tanaka, Ken Suzawa, Mikio Okazaki, Seiichiro Sugimoto, Shinichi Toyooka

Get full text